• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

副肿瘤性神经综合征患者体内针对神经胶质细胞亚群和一种66 kDa发育蛋白的抗体。

Antibodies to a subpopulation of glial cells and a 66 kDa developmental protein in patients with paraneoplastic neurological syndromes.

作者信息

Honnorat J, Antoine J C, Derrington E, Aguera M, Belin M F

机构信息

INSERM U 433, department of Neuropathology, Hôpital Neurologique, Lyon, France.

出版信息

J Neurol Neurosurg Psychiatry. 1996 Sep;61(3):270-8. doi: 10.1136/jnnp.61.3.270.

DOI:10.1136/jnnp.61.3.270
PMID:8795598
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC486550/
Abstract

BACKGROUND

Paraneoplastic neurological syndromes (PNS) are inflammatory disorders that probably depend on autoimmune processes. Several autoantibodies (anti-Hu, anti-Ri, and anti-Yo) have been characterised in PNS and proved to be helpful in the diagnosis. However, these do not account for all the cases and the possibility that other types of antibodies could be detected was investigated.

METHODS AND RESULTS

Of 45 patients with PNS whose serum was probed on paraformaldehyde fixed rat brain sections, 11 patients were identified whose serum samples recognised a cytoplasmic antigen in a subpopulation of glial cells in the white matter of adult rat brainstem, cerebellum, and spinal cord that were double labelled with a monoclonal antibody specific for oligodendrocytes. All serum samples reacted with a 66 kDa protein of newborn rat brain on western blot analysis. These antibodies were designated as anti-CV2 antibodies. Only one of the 11 patients had one of the well characterised autoantibodies (anti-Hu). Five patients had cerebellar degeneration, three had limbic encephalitis, two had encephalomyelitis, and one had Lambert-Eaton myasthenic syndrome. The tumours were small cell lung cancer or undifferentiated mediastinal cancer in seven patients, uterine sarcoma in two, and malignant thymoma in two. Among 1061 control serum samples, only two patients had anti-CV2 antibodies. One had small cell lung cancer and the other malignant thymoma.

CONCLUSIONS

The detection of anti-CV2 antibodies in patients with neurological disorders should be considered as an indication of the presence of an occult cancer.

摘要

背景

副肿瘤性神经系统综合征(PNS)是可能依赖自身免疫过程的炎症性疾病。几种自身抗体(抗Hu、抗Ri和抗Yo)已在PNS中得到鉴定,并被证明有助于诊断。然而,这些并不能解释所有病例,因此对是否能检测到其他类型抗体的可能性进行了研究。

方法与结果

在45例PNS患者中,用其血清检测经多聚甲醛固定的大鼠脑切片,发现11例患者的血清样本能识别成年大鼠脑干、小脑和脊髓白质中胶质细胞亚群的一种胞质抗原,这些胶质细胞用少突胶质细胞特异性单克隆抗体进行了双重标记。所有血清样本在蛋白质印迹分析中均与新生大鼠脑的一种66 kDa蛋白发生反应。这些抗体被命名为抗CV2抗体。11例患者中只有1例具有一种已明确的自身抗体(抗Hu)。5例患者有小脑变性,3例有边缘叶脑炎,2例有脑脊髓炎,1例有兰伯特-伊顿肌无力综合征。肿瘤在7例患者中为小细胞肺癌或未分化纵隔癌,2例为子宫肉瘤,2例为恶性胸腺瘤。在1061份对照血清样本中,只有2例患者有抗CV2抗体。1例患有小细胞肺癌,另1例患有恶性胸腺瘤。

结论

在神经系统疾病患者中检测到抗CV2抗体应被视为隐匿性癌症存在的指征。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b5d/486550/2c6d204a2efc/jnnpsyc00009-0039-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b5d/486550/16708a795654/jnnpsyc00009-0035-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b5d/486550/e7e41300ffc6/jnnpsyc00009-0036-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b5d/486550/b6f093685008/jnnpsyc00009-0036-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b5d/486550/b5a7e83d5459/jnnpsyc00009-0037-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b5d/486550/ae99830739d4/jnnpsyc00009-0037-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b5d/486550/d3e6ffee9454/jnnpsyc00009-0038-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b5d/486550/e57eb2fe3e51/jnnpsyc00009-0038-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b5d/486550/b593cb3e9953/jnnpsyc00009-0039-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b5d/486550/2c6d204a2efc/jnnpsyc00009-0039-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b5d/486550/16708a795654/jnnpsyc00009-0035-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b5d/486550/e7e41300ffc6/jnnpsyc00009-0036-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b5d/486550/b6f093685008/jnnpsyc00009-0036-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b5d/486550/b5a7e83d5459/jnnpsyc00009-0037-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b5d/486550/ae99830739d4/jnnpsyc00009-0037-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b5d/486550/d3e6ffee9454/jnnpsyc00009-0038-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b5d/486550/e57eb2fe3e51/jnnpsyc00009-0038-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b5d/486550/b593cb3e9953/jnnpsyc00009-0039-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b5d/486550/2c6d204a2efc/jnnpsyc00009-0039-b.jpg

相似文献

1
Antibodies to a subpopulation of glial cells and a 66 kDa developmental protein in patients with paraneoplastic neurological syndromes.副肿瘤性神经综合征患者体内针对神经胶质细胞亚群和一种66 kDa发育蛋白的抗体。
J Neurol Neurosurg Psychiatry. 1996 Sep;61(3):270-8. doi: 10.1136/jnnp.61.3.270.
2
Antiamphiphysin antibodies are associated with various paraneoplastic neurological syndromes and tumors.抗 amphiphysin 抗体与多种副肿瘤性神经综合征和肿瘤相关。
Arch Neurol. 1999 Feb;56(2):172-7. doi: 10.1001/archneur.56.2.172.
3
A large screen for paraneoplastic neurological autoantibodies; diagnosis and predictive values.副肿瘤神经系统自身抗体的大屏幕检测:诊断和预测价值。
Clin Immunol. 2019 Feb;199:29-36. doi: 10.1016/j.clim.2018.12.007. Epub 2018 Dec 10.
4
POP66, a paraneoplastic encephalomyelitis-related antigen, is a marker of adult oligodendrocytes.POP66是一种副肿瘤性脑脊髓炎相关抗原,是成人少突胶质细胞的标志物。
J Neuropathol Exp Neurol. 1998 Apr;57(4):311-22. doi: 10.1097/00005072-199804000-00002.
5
Anti-amphiphysin I antibodies in patients with paraneoplastic neurological disorders associated with small cell lung carcinoma.与小细胞肺癌相关的副肿瘤性神经系统疾病患者中的抗 amphiphysin I 抗体
J Neurol Neurosurg Psychiatry. 1999 Feb;66(2):214-7. doi: 10.1136/jnnp.66.2.214.
6
SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome.SOX1抗体是副肿瘤性兰伯特-伊顿肌无力综合征的标志物。
Neurology. 2008 Mar 18;70(12):924-8. doi: 10.1212/01.wnl.0000281663.81079.24. Epub 2007 Nov 21.
7
[Neurologic paraneoplastic syndromes and anti-neuronal antibodies].[神经系统副肿瘤综合征与抗神经元抗体]
Tidsskr Nor Laegeforen. 1996 Jan 30;116(3):361-5.
8
Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2/CRMP5 antibodies.肿瘤神经抗体和肿瘤类型决定了伴有Hu或CV2/CRMP5抗体的副肿瘤性神经综合征患者的生存情况和神经症状。
J Neurol Neurosurg Psychiatry. 2009 Apr;80(4):412-6. doi: 10.1136/jnnp.2007.138016. Epub 2008 Oct 17.
9
[Value of the detection of anti-nervous system autoantibodies in neurologic paraneoplastic syndromes].
Rev Med Interne. 1994 Feb;15(2):124-33. doi: 10.1016/s0248-8663(05)81186-5.
10
Autoantibodies in neurological paraneoplastic diseases.神经副肿瘤性疾病中的自身抗体。
Schweiz Arch Neurol Psychiatr (1985). 1994;145(3):3-7.

引用本文的文献

1
Anti-CV2/CRMP5 autoantibodies as drivers of sensory neuron excitability and pain in rats.抗CV2/CRMP5自身抗体作为大鼠感觉神经元兴奋性和疼痛的驱动因素。
Nat Commun. 2025 Aug 7;16(1):7311. doi: 10.1038/s41467-025-62380-y.
2
Immune Checkpoint Inhibitors Trigger and Exacerbate Anti-CV2/CRMP5 Paraneoplastic Neurologic Syndromes.免疫检查点抑制剂引发并加重抗CV2/CRMP5副肿瘤性神经系统综合征。
Neurol Neuroimmunol Neuroinflamm. 2025 Sep;12(5):e200446. doi: 10.1212/NXI.0000000000200446. Epub 2025 Jul 18.
3
Assessing Commercial Tissue-Based Assays for Autoimmune Neurologic Disorders (I): Antibodies to Intracellular Antigens.

本文引用的文献

1
Type IIa ('anti-Hu') antineuronal antibodies produce destruction of rat cerebellar granule neurons in vitro.
Neurology. 1993 Oct;43(10):2049-54. doi: 10.1212/wnl.43.10.2049.
2
Posterior uveitis, paraneoplastic encephalomyelitis and auto-antibodies reacting with developmental protein of brain and retina.
J Neurol Sci. 1993 Jul;117(1-2):215-23. doi: 10.1016/0022-510x(93)90176-y.
3
Regression of small-cell lung carcinoma in patients with paraneoplastic neuronal antibodies.伴有副肿瘤性神经元抗体的小细胞肺癌患者的肿瘤消退
Lancet. 1993 Jan 2;341(8836):21-2. doi: 10.1016/0140-6736(93)92485-c.
4
评估用于自身免疫性神经疾病的商业化组织检测方法(I):针对细胞内抗原的抗体
Neurol Neuroimmunol Neuroinflamm. 2025 Jul;12(4):e200410. doi: 10.1212/NXI.0000000000200410. Epub 2025 May 20.
4
Progressive Encephalomyelopathy in an Older Man: A Case Report From the National Multiple Sclerosis Society Case Conference Proceedings.老年进行性脑脊髓炎 1 例:国家多发性硬化症学会病例会议记录。
Neurol Neuroimmunol Neuroinflamm. 2024 May;11(3):e200210. doi: 10.1212/NXI.0000000000200210. Epub 2024 Feb 22.
5
Predicting disability and mortality in CV2/CRMP5-IgG associated paraneoplastic neurologic disorders.预测 CV2/CRMP5-IgG 相关副肿瘤性神经疾病中的残疾和死亡率。
Ann Clin Transl Neurol. 2024 Mar;11(3):710-718. doi: 10.1002/acn3.51991. Epub 2024 Jan 22.
6
Imaging-negative CV2/collapsin response mediator protein 5 antibody-related paraneoplastic myelopathy: a rare and challenging diagnosis.影像阴性的CV2/塌陷反应介导蛋白5抗体相关副肿瘤性脊髓病:一种罕见且具有挑战性的诊断。
Quant Imaging Med Surg. 2023 Aug 1;13(8):5430-5435. doi: 10.21037/qims-22-1263. Epub 2023 Jun 29.
7
Seroprevalence of autoimmune antibodies in degenerative ataxias: a broad, disease-controlled screening in 456 subjects.退行性共济失调中自身免疫抗体的血清阳性率:对456名受试者进行的广泛、疾病对照筛查。
J Neurol. 2023 Nov;270(11):5649-5654. doi: 10.1007/s00415-023-11900-1. Epub 2023 Jul 28.
8
Collapsin response mediator protein 5-associated optic neuropathy: clinical characteristics, radiologic clues, and outcomes.与萎缩素反应介导蛋白5相关的视神经病变:临床特征、影像学线索及预后
Front Neurol. 2023 Jun 28;14:1163615. doi: 10.3389/fneur.2023.1163615. eCollection 2023.
9
An overview on CV2/CRMP5 antibody-associated paraneoplastic neurological syndromes.抗CV2/CRMP5抗体相关副肿瘤性神经系统综合征概述。
Neural Regen Res. 2023 Nov;18(11):2357-2364. doi: 10.4103/1673-5374.371400.
10
Seizures, Epilepsy, and NORSE Secondary to Autoimmune Encephalitis: A Practical Guide for Clinicians.自身免疫性脑炎继发的癫痫、癫痫症和新型难治性癫痫持续状态:临床医生实用指南
Biomedicines. 2022 Dec 25;11(1):44. doi: 10.3390/biomedicines11010044.
Paraneoplastic temporal lobe epilepsy with testicular neoplasm and atypical amnesia.
Neurology. 1994 Jul;44(7):1270-4. doi: 10.1212/wnl.44.7.1270.
5
Neurologic paraneoplastic antibodies (anti-Yo; anti-Hu; anti-Ri): the case for a nomenclature based on antibody and antigen specificity.神经副肿瘤抗体(抗-Yo;抗-Hu;抗-Ri):基于抗体和抗原特异性命名的案例
Neurology. 1994 Dec;44(12):2241-6. doi: 10.1212/wnl.44.12.2241.
6
Paraneoplastic autoantibodies: the case for a descriptive generic nomenclature.副肿瘤性自身抗体:采用描述性通用命名法的理由
Neurology. 1994 Dec;44(12):2236-40. doi: 10.1212/wnl.44.12.2236.
7
Nuclear localization of anti-Hu antibody is not associated with in vitro cytotoxicity.抗Hu抗体的核定位与体外细胞毒性无关。
J Neuroimmunol. 1994 Dec;55(2):205-12. doi: 10.1016/0165-5728(94)90011-6.
8
Clinical enigmas of paraneoplastic neurologic disorders.副肿瘤性神经系统疾病的临床谜团
Clin Neurol Neurosurg. 1995 Feb;97(1):61-70. doi: 10.1016/0303-8467(95)00009-9.
9
Limbic encephalitis and immunological perturbations in two patients with thymoma.两名胸腺瘤患者的边缘叶脑炎及免疫紊乱
J Neurol Neurosurg Psychiatry. 1995 Jun;58(6):706-10. doi: 10.1136/jnnp.58.6.706.
10
Autoimmune mechanisms in the pathogenesis of paraneoplastic nervous system disease.副肿瘤性神经系统疾病发病机制中的自身免疫机制。
Clin Neurol Neurosurg. 1995 Feb;97(1):82-8. doi: 10.1016/0303-8467(95)00014-b.